| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 7.22e-07 | 4 | 114 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 7.22e-07 | 4 | 114 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 7.22e-07 | 4 | 114 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 1.80e-06 | 5 | 114 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.80e-06 | 5 | 114 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.80e-06 | 5 | 114 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.80e-06 | 5 | 114 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.80e-06 | 5 | 114 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.80e-06 | 5 | 114 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.80e-06 | 5 | 114 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 3.58e-06 | 6 | 114 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 6.24e-06 | 7 | 114 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 9.94e-06 | 8 | 114 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 9.94e-06 | 8 | 114 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 9.94e-06 | 8 | 114 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.48e-05 | 9 | 114 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.48e-05 | 9 | 114 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 2.11e-05 | 10 | 114 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 2.11e-05 | 10 | 114 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 6.30e-05 | 14 | 114 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 6.30e-05 | 14 | 114 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.95e-05 | 127 | 114 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.26e-04 | 194 | 114 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.31e-04 | 262 | 114 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.92e-04 | 4 | 114 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.92e-04 | 20 | 114 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 3.36e-04 | 24 | 114 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 4.28e-04 | 26 | 114 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 4.28e-04 | 26 | 114 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 4.80e-04 | 27 | 114 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 5.17e-04 | 115 | 114 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 6.58e-04 | 30 | 114 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 7.97e-04 | 32 | 114 | 3 | GO:0140142 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 7.97e-04 | 32 | 114 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 8.73e-04 | 33 | 114 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 9.53e-04 | 34 | 114 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.43e-03 | 39 | 114 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.54e-03 | 40 | 114 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 1.72e-03 | 11 | 114 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.72e-03 | 11 | 114 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | helicase activity | 2.14e-03 | 158 | 114 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.60e-03 | 48 | 114 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MRE11 SETX ERCC6L SMARCAL1 PSMC1 RNF213 RFC1 UBA6 DNA2 KIF2C | 2.72e-03 | 614 | 114 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | 3'-5'-DNA exonuclease activity | 3.68e-03 | 16 | 114 | 2 | GO:0008296 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.03e-03 | 56 | 114 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | lipid binding | HIP1 ANKFY1 CYP11A1 RUBCNL F3 AKR1C1 AKR1C2 MAP3K1 ITPR1 SNX14 AKR1C3 BAIAP3 MITD1 | 4.18e-03 | 988 | 114 | 13 | GO:0008289 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 4.90e-03 | 60 | 114 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 5.13e-03 | 61 | 114 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 5.37e-03 | 62 | 114 | 3 | GO:0003678 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 5.37e-03 | 62 | 114 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 5.37e-03 | 62 | 114 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 5.74e-03 | 20 | 114 | 2 | GO:0061608 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 2.94e-07 | 11 | 115 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 6.73e-07 | 4 | 115 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 6.73e-07 | 4 | 115 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 6.73e-07 | 4 | 115 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 6.73e-07 | 4 | 115 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.58e-06 | 16 | 115 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 1.67e-06 | 5 | 115 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 1.67e-06 | 5 | 115 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 1.67e-06 | 5 | 115 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 1.67e-06 | 5 | 115 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 1.67e-06 | 5 | 115 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 1.67e-06 | 5 | 115 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 3.34e-06 | 6 | 115 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 3.34e-06 | 6 | 115 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 5.81e-06 | 7 | 115 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 5.81e-06 | 7 | 115 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 5.81e-06 | 7 | 115 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 6.21e-06 | 22 | 115 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.25e-05 | 26 | 115 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.38e-05 | 9 | 115 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 1.96e-05 | 29 | 115 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.97e-05 | 10 | 115 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.97e-05 | 10 | 115 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.97e-05 | 10 | 115 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.97e-05 | 10 | 115 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.97e-05 | 10 | 115 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 2.70e-05 | 11 | 115 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 4.20e-05 | 35 | 115 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 5.88e-05 | 14 | 115 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 5.88e-05 | 14 | 115 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 7.32e-05 | 15 | 115 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | CCNJL EXOC6 MRE11 MBTPS1 KAT5 CKAP5 NCAPG2 FANCD2 BUB1 DNA2 PCID2 MITD1 LCMT1 KIF2C KCNH5 | 8.04e-05 | 854 | 115 | 15 | GO:1903047 |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 8.97e-05 | 16 | 115 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.15e-04 | 45 | 115 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 1.30e-04 | 139 | 115 | 6 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 1.30e-04 | 18 | 115 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.09e-04 | 21 | 115 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 2.09e-04 | 21 | 115 | 3 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 2.09e-04 | 21 | 115 | 3 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 2.09e-04 | 21 | 115 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 2.09e-04 | 21 | 115 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 2.17e-04 | 217 | 115 | 7 | GO:0000075 | |
| GeneOntologyBiologicalProcess | parturition | 2.41e-04 | 22 | 115 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 2.41e-04 | 22 | 115 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 2.41e-04 | 22 | 115 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 2.76e-04 | 23 | 115 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.76e-04 | 23 | 115 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 2.88e-04 | 57 | 115 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of microtubule cytoskeleton polarity | 3.05e-04 | 5 | 115 | 2 | GO:0030951 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 3.07e-04 | 163 | 115 | 6 | GO:0007093 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 3.20e-04 | 106 | 115 | 5 | GO:0050810 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 3.51e-04 | 60 | 115 | 4 | GO:0033047 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 3.55e-04 | 25 | 115 | 3 | GO:0098696 | |
| GeneOntologyBiologicalProcess | chromosome organization | MRE11 SETX KAT5 SMARCAL1 RFC1 NCAPG2 FANCD2 BUB1 DNA2 PCID2 LCMT1 KIF2C | 4.50e-04 | 686 | 115 | 12 | GO:0051276 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 4.91e-04 | 178 | 115 | 6 | GO:0006261 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 5.00e-04 | 28 | 115 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CCNJL EXOC6 MRE11 MBTPS1 KAT5 CKAP5 NCAPG2 FANCD2 BUB1 DNA2 PCID2 MITD1 LCMT1 KIF2C KCNH5 | 5.12e-04 | 1014 | 115 | 15 | GO:0000278 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 5.36e-04 | 67 | 115 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 5.55e-04 | 29 | 115 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 7.44e-04 | 32 | 115 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 8.15e-04 | 33 | 115 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet-derived growth factor receptor signaling pathway | 8.44e-04 | 8 | 115 | 2 | GO:0010641 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 8.67e-04 | 356 | 115 | 8 | GO:0098813 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 8.91e-04 | 34 | 115 | 3 | GO:0006706 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 9.07e-04 | 77 | 115 | 4 | GO:0061512 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 9.62e-04 | 135 | 115 | 5 | GO:0019218 | |
| GeneOntologyBiologicalProcess | regulation of chromosome separation | 9.99e-04 | 79 | 115 | 4 | GO:1905818 | |
| GeneOntologyBiologicalProcess | DNA repair | MRE11 EXO5 SETX KAT5 SMARCAL1 RFC1 FANCD2 KDM2A TAF6 POLG2 DNA2 | 1.00e-03 | 648 | 115 | 11 | GO:0006281 |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.05e-03 | 36 | 115 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 1.05e-03 | 36 | 115 | 3 | GO:0008299 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cytoskeleton polarity | 1.08e-03 | 9 | 115 | 2 | GO:0030952 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 1.13e-03 | 209 | 115 | 6 | GO:0006694 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 1.22e-03 | 212 | 115 | 6 | GO:0000070 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 1.24e-03 | 38 | 115 | 3 | GO:1902473 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 1.24e-03 | 38 | 115 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | regulation of receptor localization to synapse | 1.33e-03 | 39 | 115 | 3 | GO:1902683 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.44e-03 | 40 | 115 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | chromosome separation | 1.49e-03 | 88 | 115 | 4 | GO:0051304 | |
| GeneOntologyCellularComponent | condensed chromosome | 4.44e-05 | 307 | 113 | 9 | GO:0000793 | |
| GeneOntologyCellularComponent | gamma DNA polymerase complex | 8.66e-05 | 3 | 113 | 2 | GO:0005760 | |
| GeneOntologyCellularComponent | chromosomal region | 9.67e-05 | 421 | 113 | 10 | GO:0098687 | |
| GeneOntologyCellularComponent | kinetochore | 4.56e-04 | 181 | 113 | 6 | GO:0000776 | |
| GeneOntologyCellularComponent | nuclear chromosome | 4.66e-04 | 254 | 113 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 6.39e-04 | 193 | 113 | 6 | GO:0000779 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 7.61e-04 | 276 | 113 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | replication fork | 8.09e-04 | 77 | 113 | 4 | GO:0005657 | |
| MousePheno | parturition failure | 3.52e-05 | 10 | 95 | 3 | MP:0012010 | |
| MousePheno | hypermyelination | 4.82e-05 | 11 | 95 | 3 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 8.28e-05 | 13 | 95 | 3 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 1.30e-04 | 15 | 95 | 3 | MP:0005186 | |
| MousePheno | long stride length | 1.30e-04 | 15 | 95 | 3 | MP:0010540 | |
| MousePheno | long gestation period | 1.30e-04 | 15 | 95 | 3 | MP:0002293 | |
| Domain | ARM-type_fold | KPNA4 TNPO1 HIP1 CKAP5 NCAPG2 MAP3K1 ITPR1 XPO6 ZER1 TAF6 TARBP1 | 7.93e-06 | 339 | 115 | 11 | IPR016024 |
| Domain | ALDOKETO_REDUCTASE_1 | 2.64e-05 | 10 | 115 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 2.64e-05 | 10 | 115 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.64e-05 | 10 | 115 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.64e-05 | 10 | 115 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.64e-05 | 10 | 115 | 3 | PS00063 | |
| Domain | ARM-like | 4.46e-05 | 270 | 115 | 9 | IPR011989 | |
| Domain | - | 1.20e-04 | 16 | 115 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.45e-04 | 17 | 115 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 1.45e-04 | 17 | 115 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.45e-04 | 17 | 115 | 3 | IPR001395 | |
| Domain | - | 4.51e-04 | 222 | 115 | 7 | 1.25.10.10 | |
| Domain | CNMP_BINDING_1 | 9.90e-04 | 32 | 115 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 9.90e-04 | 32 | 115 | 3 | PS00889 | |
| Domain | cNMP | 1.18e-03 | 34 | 115 | 3 | SM00100 | |
| Domain | cNMP_binding | 1.18e-03 | 34 | 115 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 1.29e-03 | 35 | 115 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.29e-03 | 35 | 115 | 3 | PS50042 | |
| Domain | MIR | 1.64e-03 | 10 | 115 | 2 | PS50919 | |
| Domain | MIR | 1.64e-03 | 10 | 115 | 2 | PF02815 | |
| Domain | MIR | 1.64e-03 | 10 | 115 | 2 | SM00472 | |
| Domain | PAS_9 | 1.64e-03 | 10 | 115 | 2 | PF13426 | |
| Domain | MIR_motif | 1.64e-03 | 10 | 115 | 2 | IPR016093 | |
| Domain | cNMP-bd-like | 1.64e-03 | 38 | 115 | 3 | IPR018490 | |
| Domain | - | 1.84e-03 | 449 | 115 | 9 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.14e-03 | 459 | 115 | 9 | IPR013083 | |
| Domain | HEAT | 3.21e-03 | 48 | 115 | 3 | PF02985 | |
| Domain | - | 3.21e-03 | 48 | 115 | 3 | 2.60.120.10 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 3.26e-03 | 14 | 115 | 2 | IPR003938 | |
| Domain | IMPORTIN_B_NT | 3.26e-03 | 14 | 115 | 2 | PS50166 | |
| Domain | - | 3.74e-03 | 321 | 115 | 7 | 3.80.10.10 | |
| Domain | IBN_N | 3.74e-03 | 15 | 115 | 2 | PF03810 | |
| Domain | RmlC-like_jellyroll | 3.82e-03 | 51 | 115 | 3 | IPR014710 | |
| Domain | L_dom-like | 4.20e-03 | 328 | 115 | 7 | IPR032675 | |
| Domain | IBN_N | 4.26e-03 | 16 | 115 | 2 | SM00913 | |
| Domain | Importin-beta_N | 4.81e-03 | 17 | 115 | 2 | IPR001494 | |
| Domain | HEAT | 5.49e-03 | 58 | 115 | 3 | IPR000357 | |
| Domain | P-loop_NTPase | SETX ERCC6L SMARCAL1 PSMC1 RNF213 RFC1 MAGI2 NLRP14 NWD2 DNA2 KIF2C NLRP5 | 6.02e-03 | 848 | 115 | 12 | IPR027417 |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.50e-05 | 9 | 81 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.50e-05 | 9 | 81 | 3 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.92e-05 | 11 | 81 | 3 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.01e-05 | 13 | 81 | 3 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.01e-05 | 13 | 81 | 3 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 6.36e-05 | 14 | 81 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 6.36e-05 | 14 | 81 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 6.36e-05 | 14 | 81 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 6.36e-05 | 14 | 81 | 3 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 7.91e-05 | 15 | 81 | 3 | MM14870 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 8.49e-05 | 126 | 81 | 6 | MM15553 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.15e-04 | 44 | 81 | 4 | M499 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 1.26e-04 | 45 | 81 | 4 | M39355 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.26e-04 | 45 | 81 | 4 | MM14751 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.61e-04 | 271 | 81 | 8 | MM15388 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 2.55e-04 | 154 | 81 | 6 | M27832 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.61e-04 | 291 | 81 | 8 | M16647 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.76e-04 | 55 | 81 | 4 | M14933 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.98e-04 | 23 | 81 | 3 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.98e-04 | 23 | 81 | 3 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 2.98e-04 | 23 | 81 | 3 | MM14741 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION | 3.22e-04 | 5 | 81 | 2 | M49011 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 3.62e-04 | 59 | 81 | 4 | MM15283 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 4.32e-04 | 26 | 81 | 3 | MM15297 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 4.82e-04 | 6 | 81 | 2 | M27585 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 4.82e-04 | 6 | 81 | 2 | MM15295 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION | 4.82e-04 | 6 | 81 | 2 | M47665 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 4.84e-04 | 27 | 81 | 3 | M27586 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 5.40e-04 | 28 | 81 | 3 | MM15188 | |
| Pathway | REACTOME_CELL_CYCLE | TNPO1 MRE11 KAT5 ERCC6L CKAP5 PSMC1 RFC1 NCAPG2 BUB1 DNA2 LCMT1 KIF2C | 5.74e-04 | 694 | 81 | 12 | M543 |
| Pathway | REACTOME_CELL_CYCLE | MRE11 KAT5 ERCC6L CKAP5 PSMC1 RFC1 NCAPG2 BUB1 DNA2 LCMT1 KIF2C | 6.38e-04 | 603 | 81 | 11 | MM14635 |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 6.95e-04 | 70 | 81 | 4 | M27570 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 8.81e-04 | 33 | 81 | 3 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 8.81e-04 | 33 | 81 | 3 | MM14737 | |
| Pathway | WP_JOUBERT_SYNDROME | 9.48e-04 | 76 | 81 | 4 | M39835 | |
| Pathway | PID_ATM_PATHWAY | 9.62e-04 | 34 | 81 | 3 | M84 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 1.05e-03 | 35 | 81 | 3 | MM15293 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 1.14e-03 | 36 | 81 | 3 | MM15281 | |
| Pathway | WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS | 1.14e-03 | 9 | 81 | 2 | M46465 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 1.23e-03 | 37 | 81 | 3 | M27583 | |
| Pathway | REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA | 1.23e-03 | 37 | 81 | 3 | M27568 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 1.36e-03 | 561 | 81 | 10 | M5336 | |
| Pathway | REACTOME_CGMP_EFFECTS | 1.42e-03 | 10 | 81 | 2 | MM15054 | |
| Pathway | WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS | 1.73e-03 | 11 | 81 | 2 | M39749 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 1.91e-03 | 43 | 81 | 3 | M27588 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.93e-03 | 92 | 81 | 4 | MM15338 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.93e-03 | 92 | 81 | 4 | MM14881 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.93e-03 | 92 | 81 | 4 | M27636 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | 1.94e-03 | 308 | 81 | 7 | M1070 | |
| Pubmed | 8.14e-09 | 8 | 116 | 4 | 33584538 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 3.62e-08 | 3 | 116 | 3 | 31780644 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 21232532 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 13678667 | ||
| Pubmed | KPNA4 KDM4C ZNF423 IQSEC2 CKAP5 PSMC1 CLIC6 BHLHE40 WDR47 MAGI2 THOP1 NMT2 AKR1C3 TAF6 LNX1 ST18 TARBP1 MITD1 DOP1B | 5.16e-08 | 1285 | 116 | 19 | 35914814 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 5.70e-08 | 12 | 116 | 4 | 21256921 | |
| Pubmed | 5.70e-08 | 12 | 116 | 4 | 25774556 | ||
| Pubmed | 8.21e-08 | 13 | 116 | 4 | 24580729 | ||
| Pubmed | 1.15e-07 | 14 | 116 | 4 | 19955443 | ||
| Pubmed | MBTPS1 ANKFY1 ZNF423 CKAP5 URB2 WDR47 MAGI2 ZFR2 ST18 BAIAP3 DOP1B | 1.29e-07 | 407 | 116 | 11 | 12693553 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 1.44e-07 | 4 | 116 | 3 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 1.44e-07 | 4 | 116 | 3 | 16508162 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 1.44e-07 | 4 | 116 | 3 | 14967952 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 1.44e-07 | 4 | 116 | 3 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 1.44e-07 | 4 | 116 | 3 | 31479646 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 15222881 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 16191478 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 15577209 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 10702227 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 17034817 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 1.44e-07 | 4 | 116 | 3 | 29764944 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 10526179 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 17888864 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 17442338 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 28329705 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 16018803 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 17272929 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 1.44e-07 | 4 | 116 | 3 | 18667791 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 28259989 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 21521174 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 8274401 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 16511129 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 1.44e-07 | 4 | 116 | 3 | 34590152 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 7789999 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 3.60e-07 | 5 | 116 | 3 | 21851338 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 3.60e-07 | 5 | 116 | 3 | 17064890 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 10672042 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 38788959 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 15212687 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 3.60e-07 | 5 | 116 | 3 | 16984997 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 18003893 | ||
| Pubmed | 5.46e-07 | 20 | 116 | 4 | 24135228 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TNPO1 MRE11 LRWD1 SETX ERCC6L CKAP5 PSMC1 SRP72 FANCD2 XPO6 BUB1 KIF2C | 6.11e-07 | 582 | 116 | 12 | 20467437 |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 7.18e-07 | 6 | 116 | 3 | 29107092 | |
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 19273550 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 15860270 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 7.18e-07 | 6 | 116 | 3 | 26748576 | |
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 7.18e-07 | 6 | 116 | 3 | 17255200 | |
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 1.25e-06 | 7 | 116 | 3 | 34843575 | |
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 22529366 | ||
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 33127481 | ||
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 19846565 | ||
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 12562828 | ||
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 16337335 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 1.66e-06 | 26 | 116 | 4 | 23892084 | |
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 1.94e-06 | 27 | 116 | 4 | 14581517 | |
| Pubmed | 1.94e-06 | 27 | 116 | 4 | 23471215 | ||
| Pubmed | 2.00e-06 | 8 | 116 | 3 | 20837989 | ||
| Pubmed | 2.00e-06 | 8 | 116 | 3 | 9224647 | ||
| Pubmed | KPNA4 TNPO1 MRE11 MBTPS1 SZT2 SMARCAL1 MPDU1 TTC4 NCAPG2 FANCD2 SNX14 WDR20 KDM2A TMED10 TAF6 CRAMP1 LCMT1 | 2.01e-06 | 1327 | 116 | 17 | 32694731 | |
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 2.26e-06 | 28 | 116 | 4 | 29879378 | |
| Pubmed | 2.99e-06 | 9 | 116 | 3 | 33348080 | ||
| Pubmed | 3.93e-06 | 32 | 116 | 4 | 34288113 | ||
| Pubmed | TRERF1 MRE11 LRWD1 SETX INPP5D CKAP5 PSMC1 SRP72 RFC1 NCAPG2 ZMIZ2 TMED10 TAF6 MITD1 KIF2C | 4.16e-06 | 1103 | 116 | 15 | 34189442 | |
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 4.26e-06 | 10 | 116 | 3 | 36313771 | |
| Pubmed | 4.26e-06 | 10 | 116 | 3 | 24244276 | ||
| Pubmed | A balance between elongation and trimming regulates telomere stability in stem cells. | 4.26e-06 | 10 | 116 | 3 | 27918544 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 MRE11 SETX TTC21A IQSEC2 CKAP5 PSMC1 RNF213 NFASC ZFR2 IGSF9B DOP1B | 6.82e-06 | 736 | 116 | 12 | 29676528 |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 7.78e-06 | 12 | 116 | 3 | 28893949 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC37A1 MBTPS1 TTC21A RNF213 NFASC ST3GAL1 LRRC8D ZNF248 PTPDC1 THOP1 NACC2 UBA6 KDM2A IGSF9B BAIAP3 CRAMP1 INVS | 9.21e-06 | 1489 | 116 | 17 | 28611215 |
| Pubmed | KPNA4 MRE11 HIP1 LRWD1 SETX KAT5 CKAP5 PSMC1 SRP72 URB2 MYLK2 NMT2 WDR20 TMED10 TAF6 PCID2 KIF2C | 9.87e-06 | 1497 | 116 | 17 | 31527615 | |
| Pubmed | 1.01e-05 | 13 | 116 | 3 | 11682476 | ||
| Pubmed | 1.01e-05 | 13 | 116 | 3 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 1.01e-05 | 13 | 116 | 3 | 15117747 | |
| Pubmed | 1.01e-05 | 13 | 116 | 3 | 22863007 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 23046361 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 8573067 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 11514561 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 15492289 | ||
| Pubmed | The ligands of Numb proteins X1 and X2 are specific markers for chronic Q fever. | 1.10e-05 | 2 | 116 | 2 | 22066909 | |
| Pubmed | Local androgen inactivation in abdominal visceral adipose tissue. | 1.10e-05 | 2 | 116 | 2 | 14671194 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 36543851 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22540041 | ||
| Pubmed | AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. | 1.10e-05 | 2 | 116 | 2 | 16338060 | |
| Pubmed | Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia. | 1.10e-05 | 2 | 116 | 2 | 21324166 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 23165153 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 33675863 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 34830394 | ||
| Interaction | HDAC1 interactions | KPNA4 TRERF1 MBTPS1 ANKFY1 KAT5 KDM4C PLEKHG7 ZNF423 CKAP5 PSMC1 RFC1 TTC4 BHLHE40 STAT2 FANCD2 NACC2 ZMIZ2 BUB1 CARNMT1 PRKG1 TAF6 MXD1 HERC5 BAHCC1 | 1.08e-08 | 1108 | 114 | 24 | int:HDAC1 |
| Interaction | SIGLECL1 interactions | 3.63e-06 | 113 | 114 | 7 | int:SIGLECL1 | |
| Interaction | GYPA interactions | 6.64e-06 | 174 | 114 | 8 | int:GYPA | |
| Interaction | AKR1C4 interactions | 9.67e-06 | 8 | 114 | 3 | int:AKR1C4 | |
| Interaction | NPTN interactions | 2.91e-05 | 278 | 114 | 9 | int:NPTN | |
| Interaction | TSN interactions | 3.81e-05 | 110 | 114 | 6 | int:TSN | |
| Cytoband | 10p15-p14 | 3.13e-07 | 6 | 116 | 3 | 10p15-p14 | |
| Cytoband | 3p26 | 1.75e-04 | 8 | 116 | 2 | 3p26 | |
| Cytoband | 1p34.2 | 4.16e-04 | 57 | 116 | 3 | 1p34.2 | |
| Cytoband | 3q25.33 | 5.65e-04 | 14 | 116 | 2 | 3q25.33 | |
| GeneFamily | Aldo-keto reductases | 4.38e-05 | 15 | 85 | 3 | 399 | |
| GeneFamily | UPF1 like RNA helicases | 1.17e-03 | 11 | 85 | 2 | 1169 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 8.01e-07 | 17 | 115 | 4 | MM826 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 2.94e-06 | 200 | 115 | 8 | M4538 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 4.57e-06 | 150 | 115 | 7 | MM936 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 6.98e-06 | 160 | 115 | 7 | M8664 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN | 2.13e-05 | 190 | 115 | 7 | M384 | |
| Coexpression | GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN | 2.87e-05 | 199 | 115 | 7 | M9256 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN | 2.96e-05 | 200 | 115 | 7 | M3777 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP | 2.96e-05 | 200 | 115 | 7 | M4327 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | POMT2 ERCC6L NCAPG2 CHRNA5 ZNF248 THOP1 BUB1 UBA6 DNA2 KIF2C | 3.50e-05 | 458 | 115 | 10 | M8520 |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 6.42e-05 | 155 | 115 | 6 | M39041 | |
| Coexpression | KONG_E2F3_TARGETS | 6.96e-05 | 97 | 115 | 5 | MM1105 | |
| Coexpression | KONG_E2F3_TARGETS | 8.05e-05 | 100 | 115 | 5 | M1157 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 8.84e-05 | 102 | 115 | 5 | MM872 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 1.11e-04 | 107 | 115 | 5 | M39165 | |
| Coexpression | FERRARI_RESPONSE_TO_FENRETINIDE_UP | 1.19e-04 | 22 | 115 | 3 | M14827 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 1.29e-04 | 176 | 115 | 6 | M8952 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 1.56e-04 | 24 | 115 | 3 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.76e-04 | 25 | 115 | 3 | MM480 | |
| Coexpression | GSE15659_TREG_VS_TCONV_DN | 1.85e-04 | 188 | 115 | 6 | M3535 | |
| Coexpression | GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP | 1.90e-04 | 189 | 115 | 6 | M7569 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP | 2.26e-04 | 195 | 115 | 6 | M3184 | |
| Coexpression | GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP | 2.45e-04 | 198 | 115 | 6 | M4432 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_UP | 2.52e-04 | 199 | 115 | 6 | M5145 | |
| Coexpression | GSE3982_DC_VS_TH1_DN | 2.52e-04 | 199 | 115 | 6 | M5482 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 2.52e-04 | 199 | 115 | 6 | M9236 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.52e-04 | 199 | 115 | 6 | M9184 | |
| Coexpression | GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M9475 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP | 2.58e-04 | 200 | 115 | 6 | M9591 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN | 2.58e-04 | 200 | 115 | 6 | M5262 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP | 2.58e-04 | 200 | 115 | 6 | M3778 | |
| Coexpression | GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP | 2.58e-04 | 200 | 115 | 6 | M4089 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 2.30e-05 | 105 | 115 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.02e-07 | 191 | 116 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.27e-07 | 192 | 116 | 7 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 8.35e-07 | 196 | 116 | 7 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 9.56e-07 | 200 | 116 | 7 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 130 | 116 | 6 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.07e-06 | 143 | 116 | 6 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-06 | 163 | 116 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-06 | 180 | 116 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-06 | 180 | 116 | 6 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.54e-06 | 183 | 116 | 6 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 9.37e-06 | 186 | 116 | 6 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 189 | 116 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-05 | 190 | 116 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-05 | 191 | 116 | 6 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.09e-05 | 191 | 116 | 6 | 72e3191990973440e4f91427208df360f73e4f41 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 192 | 116 | 6 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 192 | 116 | 6 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 192 | 116 | 6 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.16e-05 | 193 | 116 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 194 | 116 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.19e-05 | 194 | 116 | 6 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.23e-05 | 195 | 116 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 196 | 116 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 196 | 116 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 197 | 116 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.34e-05 | 198 | 116 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-05 | 198 | 116 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-05 | 198 | 116 | 6 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-05 | 198 | 116 | 6 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-05 | 198 | 116 | 6 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 199 | 116 | 6 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.38e-05 | 199 | 116 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 1.41e-05 | 200 | 116 | 6 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.41e-05 | 200 | 116 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-05 | 200 | 116 | 6 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.41e-05 | 200 | 116 | 6 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-05 | 200 | 116 | 6 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.41e-05 | 200 | 116 | 6 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.41e-05 | 200 | 116 | 6 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.99e-05 | 126 | 116 | 5 | 518a6e4919981b556ce6b451a91270dba976bc75 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-05 | 129 | 116 | 5 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-05 | 132 | 116 | 5 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.08e-05 | 138 | 116 | 5 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.59e-05 | 150 | 116 | 5 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.36e-05 | 155 | 116 | 5 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.53e-05 | 156 | 116 | 5 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.53e-05 | 156 | 116 | 5 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.05e-05 | 159 | 116 | 5 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.42e-05 | 161 | 116 | 5 | d1f2e5245c7c247b684f48f9f877e149a3ee7c06 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.81e-05 | 163 | 116 | 5 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-05 | 166 | 116 | 5 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.42e-05 | 166 | 116 | 5 | 941d6aa94ab9d36e5f6c40f446c926754e070d56 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 166 | 116 | 5 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.42e-05 | 166 | 116 | 5 | 6f5ecf3b2cf613ae0535ab3d21d93622f1497571 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-05 | 169 | 116 | 5 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 169 | 116 | 5 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-05 | 169 | 116 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 169 | 116 | 5 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-05 | 169 | 116 | 5 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 8.30e-05 | 170 | 116 | 5 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 170 | 116 | 5 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.30e-05 | 170 | 116 | 5 | 4b1c84b35b7242a297ffdb9c23a6d982acf1bed5 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Developing_Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.30e-05 | 170 | 116 | 5 | cfd7f29805b7c51666b0eaf269c36c96b8765a1a | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 8.53e-05 | 171 | 116 | 5 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.77e-05 | 172 | 116 | 5 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 173 | 116 | 5 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-05 | 174 | 116 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.51e-05 | 175 | 116 | 5 | aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.51e-05 | 175 | 116 | 5 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.51e-05 | 175 | 116 | 5 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.77e-05 | 176 | 116 | 5 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 9.77e-05 | 176 | 116 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 9.77e-05 | 176 | 116 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.00e-04 | 177 | 116 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 1.00e-04 | 177 | 116 | 5 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-04 | 177 | 116 | 5 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 1.03e-04 | 178 | 116 | 5 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 178 | 116 | 5 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 179 | 116 | 5 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 179 | 116 | 5 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 180 | 116 | 5 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | control-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.09e-04 | 180 | 116 | 5 | 535535a67b3f3320bad2f98b1bc98a7b0ee77840 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 180 | 116 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.11e-04 | 181 | 116 | 5 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-04 | 181 | 116 | 5 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.11e-04 | 181 | 116 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-04 | 181 | 116 | 5 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.14e-04 | 182 | 116 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.14e-04 | 182 | 116 | 5 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | NS-control-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.14e-04 | 182 | 116 | 5 | f623c47e7806181d09f126066a952162ce49a306 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.17e-04 | 183 | 116 | 5 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 1.20e-04 | 184 | 116 | 5 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 1.23e-04 | 185 | 116 | 5 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.23e-04 | 185 | 116 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 185 | 116 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 186 | 116 | 5 | 305f1726b8b5add32f1c29c74991ff34f42e0da7 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-04 | 186 | 116 | 5 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.27e-04 | 186 | 116 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-04 | 186 | 116 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 187 | 116 | 5 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| Drug | 4-hydroxybenzoic acid | 7.90e-08 | 9 | 116 | 4 | ctd:C038193 | |
| Drug | cyclopentanol | 1.29e-07 | 3 | 116 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 1.29e-07 | 3 | 116 | 3 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 1.29e-07 | 3 | 116 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.29e-07 | 3 | 116 | 3 | ctd:C530610 | |
| Drug | cloxazolam | 5.14e-07 | 4 | 116 | 3 | ctd:C005522 | |
| Drug | Pregnanes | 5.14e-07 | 4 | 116 | 3 | ctd:D011278 | |
| Drug | tetralol | 5.14e-07 | 4 | 116 | 3 | ctd:C019106 | |
| Drug | gliquidone | 5.14e-07 | 4 | 116 | 3 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 5.14e-07 | 4 | 116 | 3 | ctd:C018156 | |
| Drug | Hydroxysteroids | 1.28e-06 | 5 | 116 | 3 | ctd:D006914 | |
| Drug | NSC86000 | 1.28e-06 | 5 | 116 | 3 | CID000257630 | |
| Drug | cresolphthalein | 1.28e-06 | 5 | 116 | 3 | ctd:C010092 | |
| Drug | Estazolam | 2.55e-06 | 6 | 116 | 3 | ctd:D004949 | |
| Drug | Glipizide | 2.55e-06 | 6 | 116 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 2.55e-06 | 6 | 116 | 3 | ctd:C023723 | |
| Drug | Medazepam | 2.55e-06 | 6 | 116 | 3 | ctd:D008472 | |
| Drug | 4-hydroxyequilenin-o-quinone | 4.44e-06 | 7 | 116 | 3 | ctd:C117714 | |
| Drug | zomepirac | 4.44e-06 | 7 | 116 | 3 | ctd:C020549 | |
| Drug | Nitrazepam | 7.08e-06 | 8 | 116 | 3 | ctd:D009567 | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 7.51e-06 | 196 | 116 | 8 | 3217_DN | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 8.39e-06 | 199 | 116 | 8 | 3264_UP | |
| Drug | 20-alpha-Dihydroprogesterone | 1.06e-05 | 9 | 116 | 3 | ctd:D004092 | |
| Drug | NSC36919 | 1.16e-05 | 58 | 116 | 5 | CID000235496 | |
| Drug | octyl gallate | 1.51e-05 | 10 | 116 | 3 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 2.06e-05 | 11 | 116 | 3 | ctd:D004101 | |
| Drug | chlordecone alcohol | 2.06e-05 | 11 | 116 | 3 | CID000013946 | |
| Drug | alpha-methylcinnamic acid | 2.57e-05 | 2 | 116 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 2.57e-05 | 2 | 116 | 2 | DB07768 | |
| Drug | baccharin | 2.57e-05 | 2 | 116 | 2 | ctd:C012764 | |
| Drug | fenamic acid | 2.74e-05 | 12 | 116 | 3 | ctd:C001209 | |
| Drug | Phenolphthalein | 2.74e-05 | 12 | 116 | 3 | ctd:D020113 | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.49e-05 | 177 | 116 | 7 | 841_DN | |
| Drug | DMBA-3,4-dihydrodiol | 3.55e-05 | 13 | 116 | 3 | CID000050096 | |
| Drug | flunisolide | 3.55e-05 | 13 | 116 | 3 | ctd:C007734 | |
| Drug | Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 3.88e-05 | 180 | 116 | 7 | 3279_UP | |
| Drug | staurosporine; Down 200; 1uM; MCF7; HG-U133A | 4.02e-05 | 181 | 116 | 7 | 312_DN | |
| Drug | Dydrogesterone | 4.50e-05 | 14 | 116 | 3 | ctd:D004394 | |
| Drug | 5-alpha-Dihydroprogesterone | 4.50e-05 | 14 | 116 | 3 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 4.50e-05 | 14 | 116 | 3 | CID000022750 | |
| Drug | Meclofenamic Acid | 4.50e-05 | 14 | 116 | 3 | ctd:D008469 | |
| Drug | Mefenamic Acid | 4.58e-05 | 39 | 116 | 4 | ctd:D008528 | |
| Drug | 20 alpha-dihydroprogesterone | 5.07e-05 | 40 | 116 | 4 | CID000008956 | |
| Drug | glycidamide | 5.48e-05 | 130 | 116 | 6 | ctd:C071834 | |
| Drug | NAD | 5.58e-05 | 80 | 116 | 5 | ctd:D009243 | |
| Drug | o-quinone | 5.60e-05 | 41 | 116 | 4 | CID000011421 | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 6.44e-05 | 195 | 116 | 7 | 2624_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 6.44e-05 | 195 | 116 | 7 | 3721_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A | 6.65e-05 | 196 | 116 | 7 | 4283_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HT_HG-U133A | 6.87e-05 | 197 | 116 | 7 | 6683_UP | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.87e-05 | 197 | 116 | 7 | 1514_UP | |
| Drug | 9-cis-retinal | 6.88e-05 | 16 | 116 | 3 | ctd:C031390 | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 7.09e-05 | 198 | 116 | 7 | 6347_UP | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | 7.32e-05 | 199 | 116 | 7 | 1729_UP | |
| Drug | Nitrocaramiphen hydrochloride; Down 200; 10.8uM; HL60; HT_HG-U133A | 7.32e-05 | 199 | 116 | 7 | 3125_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; PC3; HG-U133A | 7.32e-05 | 199 | 116 | 7 | 1954_UP | |
| Drug | 5-dihydrodeoxycorticosterone | 7.69e-05 | 3 | 116 | 2 | ctd:C454687 | |
| Drug | 4-cyanobenzaldehyde | 7.69e-05 | 3 | 116 | 2 | CID000066042 | |
| Drug | naphthalene-1,2-dihydrodiol | 8.11e-05 | 45 | 116 | 4 | CID000000362 | |
| Drug | benzo(a)pyrene-1,6-quinone | 8.32e-05 | 17 | 116 | 3 | ctd:C030233 | |
| Drug | helenalin | 9.29e-05 | 89 | 116 | 5 | CID000023205 | |
| Drug | cloxazolam | 9.94e-05 | 18 | 116 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 9.94e-05 | 18 | 116 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 9.94e-05 | 18 | 116 | 3 | ctd:C018003 | |
| Drug | oxcarbazepine | 1.18e-04 | 19 | 116 | 3 | ctd:C036006 | |
| Drug | androstane-3,17-dione | 1.33e-04 | 51 | 116 | 4 | CID000000443 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.38e-04 | 20 | 116 | 3 | ctd:C076588 | |
| Drug | MRS2159 | 1.38e-04 | 20 | 116 | 3 | CID006258690 | |
| Drug | Chrysenes | 1.38e-04 | 20 | 116 | 3 | ctd:D002911 | |
| Drug | 1,1,1-trichloroethane | 1.50e-04 | 156 | 116 | 6 | CID000006278 | |
| Drug | tetrahydrodeoxycorticosterone | 1.53e-04 | 4 | 116 | 2 | ctd:C009413 | |
| Drug | DBD-H | 1.53e-04 | 4 | 116 | 2 | CID000131382 | |
| Drug | cadmium sulfate | 1.57e-04 | 301 | 116 | 8 | ctd:C037123 | |
| Drug | Flunitrazepam | 1.60e-04 | 21 | 116 | 3 | ctd:D005445 | |
| Drug | coniferaldehyde | 1.60e-04 | 21 | 116 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 1.60e-04 | 21 | 116 | 3 | ctd:D000068538 | |
| Drug | Eugenol | 1.75e-04 | 229 | 116 | 7 | ctd:D005054 | |
| Drug | CTK2I5299 | 1.79e-04 | 55 | 116 | 4 | CID005310955 | |
| Drug | benzene dihydrodiol | 1.85e-04 | 22 | 116 | 3 | CID000000418 | |
| Drug | 1,2-dihydroxynaphthalene | 2.05e-04 | 57 | 116 | 4 | CID000011318 | |
| Drug | Sodium Dodecyl Sulfate | 2.12e-04 | 106 | 116 | 5 | ctd:D012967 | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 2.12e-04 | 23 | 116 | 3 | DB03461 | |
| Drug | medazepam | 2.41e-04 | 24 | 116 | 3 | CID000004041 | |
| Drug | Glycyrrhetinic Acid | 2.41e-04 | 24 | 116 | 3 | ctd:D006034 | |
| Drug | farnesal | 2.55e-04 | 5 | 116 | 2 | ctd:C084519 | |
| Drug | 9,10-phenanthrenequinone | 2.73e-04 | 25 | 116 | 3 | ctd:C005399 | |
| Drug | Pregnanolone | 2.73e-04 | 25 | 116 | 3 | ctd:D011280 | |
| Disease | Neoplasms, Hormone-Dependent | 4.90e-08 | 3 | 109 | 3 | C0027661 | |
| Disease | Hermaphroditism | 4.88e-07 | 5 | 109 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 4.88e-07 | 5 | 109 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 4.88e-07 | 5 | 109 | 3 | C0033804 | |
| Disease | Intersex Conditions | 4.88e-07 | 5 | 109 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 4.88e-07 | 5 | 109 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 1.70e-06 | 7 | 109 | 3 | C0036875 | |
| Disease | Cerebellar Hemiataxia | 8.07e-05 | 4 | 109 | 2 | C0750994 | |
| Disease | Cerebellar Dysmetria | 8.07e-05 | 4 | 109 | 2 | C0234162 | |
| Disease | Hypermetria (finding) | 8.07e-05 | 4 | 109 | 2 | C3668822 | |
| Disease | Adiadochokinesis | 8.07e-05 | 4 | 109 | 2 | C0234357 | |
| Disease | Cerebellar Ataxia | 1.34e-04 | 5 | 109 | 2 | C0007758 | |
| Disease | hypogonadism (biomarker_via_orthology) | 1.34e-04 | 5 | 109 | 2 | DOID:1924 (biomarker_via_orthology) | |
| Disease | cortolone glucuronide (1) measurement | 2.01e-04 | 6 | 109 | 2 | EFO_0800552 | |
| Disease | NEPHRONOPHTHISIS 2 | 3.73e-04 | 8 | 109 | 2 | C1865872 | |
| Disease | rectum cancer (is_implicated_in) | 4.79e-04 | 9 | 109 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | B-lymphoblastic leukemia/lymphoma (is_implicated_in) | 5.97e-04 | 10 | 109 | 2 | DOID:0080630 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.21e-04 | 45 | 109 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Endometrial Neoplasms | 1.31e-03 | 58 | 109 | 3 | C0014170 | |
| Disease | vision disorder | 1.57e-03 | 16 | 109 | 2 | MONDO_0021084 | |
| Disease | response to methotrexate | 1.57e-03 | 16 | 109 | 2 | GO_0031427 | |
| Disease | posterior cingulate cortex volume measurement | 1.77e-03 | 17 | 109 | 2 | EFO_0010324 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.22e-03 | 19 | 109 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Endometrial Carcinoma | 2.43e-03 | 72 | 109 | 3 | C0476089 | |
| Disease | coagulation factor measurement | 2.46e-03 | 20 | 109 | 2 | EFO_0004634 | |
| Disease | serum metabolite measurement | TNPO1 KDM4C CKAP5 ST3GAL1 MAGI2 NWD2 SLCO1A2 AKR1C3 LNX1 HERPUD1 | 2.65e-03 | 945 | 109 | 10 | EFO_0005653 |
| Disease | pulmonary function measurement | 2.94e-03 | 77 | 109 | 3 | EFO_0003892 | |
| Disease | CCL24 measurement | 2.98e-03 | 22 | 109 | 2 | EFO_0009418 | |
| Disease | Endometrioma | 3.05e-03 | 161 | 109 | 4 | C0269102 | |
| Disease | Endometriosis | 3.05e-03 | 161 | 109 | 4 | C0014175 | |
| Disease | Alcoholic Intoxication, Chronic | 3.23e-03 | 268 | 109 | 5 | C0001973 | |
| Disease | cotinine measurement | 3.25e-03 | 23 | 109 | 2 | EFO_0007813 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLKTLISLNHLILEP | 411 | Q14146 | |
| ALPRKAITHLKKRSC | 71 | Q5JWF8 | |
| RPKHLTSCLLNTKVL | 276 | Q9P281 | |
| CHHLPSLDLLRQKLK | 1041 | O43683 | |
| LLPQFLLHLDKIRKC | 101 | Q8N4J0 | |
| VHRLELLLKCLGKLQ | 531 | O94812 | |
| LCALAKKHKRTPALI | 241 | P42330 | |
| CIAQLKDLLPEHLKL | 71 | O14503 | |
| LENPCSLKHLCRLKI | 531 | Q8WXK1 | |
| HCTLREKELKLPTFR | 16 | Q8IV13 | |
| LTLADCNLLPKLHII | 636 | Q96NY7 | |
| LPNKHGILQKLRCLI | 546 | Q9ULI1 | |
| VVSSLPKLRHLLLEC | 921 | Q9ULI1 | |
| LAPLLKDILKASLAH | 576 | Q9H714 | |
| KLPHCRKLVLLCFLL | 6 | Q9Y5H1 | |
| KLLLDHQCLRDLLPK | 61 | Q15011 | |
| KVAAIRKSPFILLHC | 206 | Q9ULD8 | |
| LELLSEHLDPKLLCR | 31 | Q9UFC0 | |
| RLLCHKCSTKEIPII | 1131 | Q9P2R3 | |
| ASLIHHTKLCLEKPL | 236 | Q9H790 | |
| PLLKLVCIDTHTLGL | 181 | Q96R67 | |
| LHRVKPAVCSLLPKE | 246 | Q8N4N3 | |
| LEHLDRPQLVALCKL | 286 | Q2VYF4 | |
| KEHLEHLLRCLKNPL | 281 | Q5VTA0 | |
| HLRLCLEKLKGLVPL | 71 | Q05195 | |
| DVLAVIKHCKDPLRL | 81 | Q86UL8 | |
| CVHKKLRSKRVAPVL | 251 | O60551 | |
| IWLLLLVVLLCGKKH | 6 | Q14703 | |
| LRLTKILLAILDCVH | 886 | Q14643 | |
| LKRKLHKCQSVLPVP | 36 | Q13976 | |
| LLISKRLAQCLHPAL | 61 | Q9Y3R5 | |
| KKPVLSLPHRRLVCC | 961 | Q5JU85 | |
| RLLRIDSKCLHFTPK | 491 | Q92993 | |
| CDLHIIKREALLKVL | 636 | Q8NCM2 | |
| ILVHKLLDKLLVLCP | 101 | Q8N448 | |
| RVLHLDLKPENILCV | 401 | Q9H1R3 | |
| LLRDILHKTVKHPVC | 46 | Q96G04 | |
| IPLQRLKLKCIFCRH | 801 | Q9H3R0 | |
| KLLNKLLVTCPFREH | 96 | Q8TBB1 | |
| VLKLHPCLAPIKVAL | 371 | Q9UHN1 | |
| LKHPKCLLESLRLDC | 861 | P59047 | |
| TKIKLCILLHAFRIR | 191 | P29459 | |
| LLKHVPKIIHLVCKL | 281 | A2A3K4 | |
| PKIIHLVCKLLLDLA | 286 | A2A3K4 | |
| TFLLPREKQLREHCK | 116 | A6NF36 | |
| SCLLNLIRKPHIGLT | 531 | Q8TAG9 | |
| TTCLKDNLLKRLPFH | 466 | Q9UII4 | |
| LECRVKHDPSLKLTV | 541 | O94856 | |
| KINKLHLCKPLIRAI | 181 | Q5JVF3 | |
| LLFLIRLIHKELSCP | 506 | P57057 | |
| LVRKIFLHTLPKLLC | 351 | P30532 | |
| PIRTLKTLLHTLCKL | 1756 | Q14008 | |
| TLCKLKGPKILDHLT | 1766 | Q14008 | |
| LRCLVDKLESLPLHK | 461 | Q9Y2K7 | |
| PTALHKQRLLSCLLK | 721 | Q96RY5 | |
| IAKCPLRTKTGHILK | 41 | A2RUB6 | |
| LLKASIKETLRLHPI | 376 | P05108 | |
| RAKHKLILLGCVPSL | 1006 | P51530 | |
| LKLKCVAHLGRTKVL | 941 | Q6ZTR5 | |
| ISIPSKCLLLVHEPK | 281 | Q99661 | |
| VLKKLCDHPRLLSAR | 406 | Q2NKX8 | |
| HVPLLKKTLELLVCR | 1356 | Q9BXW9 | |
| IISFQHLKRLTCLKL | 676 | Q7L1W4 | |
| TTRHRSPKCLALLLK | 121 | Q9Y283 | |
| PCHSLAERIKLQRLL | 666 | Q13233 | |
| TVLCDLLLLHILPKR | 346 | P51575 | |
| LLLKHCAPVLAKLRP | 426 | P49848 | |
| RPCLVVLHKPLDKLL | 736 | Q5T011 | |
| VLEKSLHCSVLKPLR | 431 | Q13671 | |
| HLRQLLKELKGLSCL | 271 | P52630 | |
| GKHLTARVLCLIVLP | 276 | Q9UKY4 | |
| RLHKVVRKLVPSCDV | 426 | Q2TB90 | |
| IVTRKLHSIKCKPPL | 126 | Q9UIC8 | |
| LIKRPCKVKTIHLLT | 141 | Q8WV92 | |
| ELIGLIKHTKIPIIC | 736 | P35251 | |
| KLLFKLHSCLPADTL | 241 | O00291 | |
| LEEHSKLIAKVRCLP | 376 | Q9NZC9 | |
| LPHLKKLTTLLCKEL | 206 | Q92835 | |
| LSENLKRLIKHRPCT | 46 | Q11201 | |
| LCLLPLIVKHIRKKQ | 131 | Q8N7X8 | |
| TLTPLIHRCNKLILV | 2191 | Q7Z333 | |
| PLLEPLICKKIAHER | 521 | Q8TBZ3 | |
| LICKKIAHERLTVLI | 526 | Q8TBZ3 | |
| ALIILILLRKCHLPG | 616 | P46721 | |
| LVTPHTQCRLKLLKL | 51 | P62191 | |
| KACLILRSIEELKHK | 391 | O76094 | |
| KPSRKTLHTCLELLR | 66 | P49959 | |
| PFREILCKKLHIPLK | 301 | Q15391 | |
| DLLHVPCLKILLSKG | 31 | O75352 | |
| KLHARDLKKELITCP | 711 | O60284 | |
| LCALAKKHKRTPALI | 241 | Q04828 | |
| LCALAKKHKRTPALI | 241 | P52895 | |
| CLLSAPRKKLNHLLK | 776 | Q86XI2 | |
| DKLPRHKKLERLCLT | 2366 | Q63HN8 | |
| HKKLERLCLTLGIPQ | 2371 | Q63HN8 | |
| LQLLHCFPLDIRLKD | 716 | A0AVT1 | |
| KLCLLLTLPRLTNHA | 136 | O94967 | |
| LRALKLVITALKCHK | 391 | Q7Z7L7 | |
| LALLCSEKPTHSLLR | 676 | Q9UPR6 | |
| KVKCKRHRPSLLLEN | 106 | Q9Y5W7 | |
| LPINSRKCLREEIHK | 36 | P49755 | |
| LKRKKDPPLSITHCR | 756 | Q9UPX0 | |
| LLAGLVSLLCRHKRK | 491 | P14679 | |
| VSLLCRHKRKQLPEE | 496 | P14679 | |
| LVIILAISLHKCRKA | 266 | P13726 | |
| SLHLKKIIVVSRLCG | 296 | Q8NDW8 | |
| ICKDVLVRHLPKLIP | 296 | Q92973 | |
| KRLLPAEHCITKIKR | 556 | Q8NF64 | |
| CGLFLILLALHRAKK | 176 | Q8IYP9 | |
| RLVAEKLSPCLHKIL | 1016 | O95789 | |
| CHPLLLLNSESKKPR | 211 | Q6ZR37 | |
| PVFHCLKVLVPKLLT | 946 | Q13395 | |
| LKLHLELLLRKQACP | 651 | Q2M1K9 | |
| LSTHLLKKCPVLLRK | 881 | P52746 | |
| EIRSCLPKLLLAHHK | 86 | Q96QU8 | |
| PLLKKCHVPETRRKV | 226 | P52888 | |
| TAARKLKPCHLKAII | 141 | O95801 | |
| LKAIIRGALCHLELK | 151 | O95801 | |
| CEKLLLDIRHEKIPI | 171 | Q8NDW4 | |
| LLLRKPVRLKCHPLA | 866 | Q96PN7 | |
| IKSGILPILVHCLER | 111 | O00629 | |
| EALKHPECKLQTLRL | 751 | Q86W24 | |
| LCAGVKHKVLLRRLL | 366 | Q96BF6 |